• Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Heterozygous (PubMed=27750403).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val172Phe (c.514G>T); ClinVar=VCV000428909; Zygosity=Heterozygous (PubMed=27750403).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238Tyr (c.713G>A); ClinVar=VCV000182935; Zygosity=Heterozygous (PubMed=27750403).
  

PubMed=9266938; DOI=10.1046/j.1365-2141.1997.2413058.x
Nagai M., Fujita M., Ikeda T., Ohmori M., Kuwabara H., Yamaoka G., Tanaka K., Kamada N., Taniwaki M., Inoue T., Irino S., Takahara J.
Alterations of p53 and Rb genes in a novel human GM-CSF-dependent myeloid cell line (OHN-GM) established from therapy-related leukaemia.
Br. J. Haematol. 98:392-398(1997)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

PubMed=27750403; DOI=10.1002/gcc.22430
Palau A., Mallo M., Palomo L., Rodriguez-Hernandez I., Diesch J., Campos D., Granada I., Junca J., Drexler H.G., Sole F., Buschbeck M.
Immunophenotypic, cytogenetic, and mutational characterization of cell lines derived from myelodysplastic syndrome patients after progression to acute myeloid leukemia.
Genes Chromosomes Cancer 56:243-252(2017)

PubMed=29533902; DOI=10.1515/hsz-2017-0321
Drexler H.G., Pommerenke C., Eberth S., Nagel S.
Hodgkin lymphoma cell lines: to separate the wheat from the chaff.
Biol. Chem. 399:511-523(2018)